Pharmaceutical company AstraZeneca will put an experimental coronavirus vaccine study on hold in America after a participant in the United Kingdom faced an apparent serious adverse reaction, according to a report. It’s suspected the adverse reaction happened in the Phase 2/3 trial underway in the U.K.A Phase 1/2 study published in July reported about 60% of 1,000 participants on the vaccine experienced side effects. The AstraZeneca vaccine, known as AZD1222, was invented by the University of Oxford and an associated company, Vaccitech. The company said that monoclonal antibodies are created in the lab, mimic natural antibodies, and their treatment may prevent disease progression. The monoclonal antibodies are derived from the convalescent plasma of COVID-19 patients.

Source: Fox News September 08, 2020 23:48 UTC